MedPath

VRC-01-LS

Generic Name
VRC-01-LS

Dual bNAb Treatment in Children

Phase 1
Completed
Conditions
HIV Infection
Interventions
First Posted Date
2018-10-16
Last Posted Date
2025-05-14
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
30
Registration Number
NCT03707977
Locations
🇧🇼

Francistown Non-Network CRS, Francistown, Botswana

🇧🇼

Botswana Harvard AIDS Institute Partnership CRS Non-Network, Gaborone, Botswana

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

Phase 1
Completed
Conditions
HIV-1
Interventions
First Posted Date
2016-07-21
Last Posted Date
2025-01-30
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
16
Registration Number
NCT02840474
Locations
🇺🇸

University of Alabama HIV Clinic Clinical Research Site, AIDS Clinical Trials Group (ACTG), Birmingham, Alabama, United States

🇺🇸

University of Cincinnati University Hospital, AIDS Clinical Trials Group (ACTG), Cincinnati, Ohio, United States

🇺🇸

Washington University Therapeutics, AIDS Clinical Trials Group (ACTG), Saint Louis, Missouri, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath